Drugs.com
AUGUST 30, 2024
FRIDAY, Aug.30, 2024 -- New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways.These two injected drugs are versions of semaglutide. In multiple new data analyses, the drugs.
Science Daily: Pharmacology News
AUGUST 30, 2024
Facial recognition is a critical part of self-image and social interactions. In an era of advanced digital technology, we face intriguing questions about communication and identity. How does altering our facial identity affect our sense of 'self' and our interactions with others?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drugs.com
AUGUST 30, 2024
FRIDAY, Aug. 30, 2024 -- Senior residential homes are breeding grounds for antibiotic-resistant bacteria, due to overprescription of antibiotics, a new study says.Stool samples provided by Australian senior home residents contained bacteria with a.
NIOSH Science Blog: Drugs
AUGUST 30, 2024
Each Labor Day we honor workers and the role they play in building a strong and prosperous nation. Much like the first Labor Day more than a century ago, many of us mark this federal holiday with festivities such as parades or picnics. This year, as you head out to celebrate the end of summer with friends and loved ones, I urge you to take a moment to reflect on the contributions of the workers all around us.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drugs.com
AUGUST 30, 2024
FRIDAY, Aug. 30, 2024 -- A new, tougher rule on the sale of tobacco products will require retailers to check the IDs of any buyers under the age of 30, the U.S. Food and Drug Administration announced Thursday.The final rule, which will go into.
Science Daily: Pharmacology News
AUGUST 30, 2024
Researchers have uncovered a surprising genetic mechanism that influences the vibrant and complex patterns on butterfly wings. The team discovered that an RNA molecule, rather than a protein as previously thought, plays a pivotal role in determining the distribution of black pigment on butterfly wings.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Science Daily: Pharmacology News
AUGUST 30, 2024
Geologists examined a submerged 25-foot bridge to tackle a long-lasting archaeological controversy: When humans settled on the islands in the western Mediterranean. Their findings narrow a historical gap between the settlement timelines of the eastern and western Mediterranean regions.
Drugs.com
AUGUST 30, 2024
FRIDAY, August 30, 2024 — Teaching schoolkids to practice mindfulness can boost their mental health — and, maybe, even their grades.That's the takeaway from a new review of more than three dozen research studies on school-based mindfulness int.
Science Daily: Pharmacology News
AUGUST 30, 2024
A doughnut-shaped region thousands of kilometers beneath our feet within Earth's liquid core has been discovered, providing new clues about the dynamics of our planet's magnetic field.
Drugs.com
AUGUST 30, 2024
FRIDAY, Aug. 30, 2024 -- People who challenge an unexpected medical bill often get some form of financial relief, a new study says.About 1 in 5 people say they’ve recently received a medical bill they disagreed with or couldn’t afford to pay, acc.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
BioPharma Drive: Drug Pricing
AUGUST 30, 2024
Detailed results from the Helios-B study support summary findings disclosed in June. But they may not make vutrisiran the standard of care as easily as Alnylam hopes.
Drugs.com
AUGUST 30, 2024
FRIDAY, Aug. 30, 2024 -- Fluorescent light can be used to highlight bacteria that hides in wounds, causing infections and slowing down the healing process, a new evidence review says.A handheld fluorescent device can light up bacteria in 9 out of.
BioPharma Drive: Drug Pricing
AUGUST 30, 2024
A new analysis showed semaglutide reduced the risk of worsening heart failure. Elsewhere, the FDA approved a vaccine for mpox and a biotech planned layoffs.
Drugs.com
AUGUST 30, 2024
FRIDAY, Aug. 30, 2024 -- People can create many special moments if they include a loved one with dementia in their end-of-summer Labor Day getaway.However, they’ll need to take some special steps to make traveling as smooth as possible, according t.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drug Target Review
AUGUST 30, 2024
Can you tell me more about your journey in the field of STEM and the challenges you encountered along the way? I started by studying pharmaceutical sciences with the initial plan of becoming a pharmacist and owning my own pharmacy. However, I pursued an additional year in industrial pharmacy, where I learned a lot about manufacturing and drug development, which I found really fascinating.
Drugs.com
AUGUST 30, 2024
FRIDAY, Aug. 30, 2024 -- More than half of people around the world aren’t getting enough micronutrients essential to human health, including calcium, iron and vitamins C and E, a new study says.These deficiencies are contributing to global m.
Fierce BioTech
AUGUST 30, 2024
Let's dive into a conversation with Ayla Ellison, Fierce Biotech Editor-in-Chief and Michelle Benz as they discuss the highlights and excitement surrounding this year's Fierce Biotech Summit. | Join Fierce Biotech Editors at Fierce Biotech Summit on Sept. 30-Oct.1 in Boston to learn, connect, and innovate with your industry peers.
Drugs.com
AUGUST 30, 2024
FRIDAY, Aug. 30, 2024 -- Rural hospitals – and their patients -- are particularly vulnerable to the aftershocks caused by ransomware attacks, a new study reports.“Ransomware attacks are bad news for hospitals and patients no matter where they hap.
Alta Sciences
AUGUST 30, 2024
How We Used Singlicate Analysis to Optimize Resource Utilization blussier Fri, 08/30/2024 - 14:51 HTML Achieving Efficiency and Cost Savings in Drug Development In the fast-paced world of drug development, where every sample counts, finding ways to optimize resources and accelerate results is critical. In this poster presentation, we discuss singlicate analysis, an innovative approach that focuses on individual samples to streamline processes.
Agency IQ
AUGUST 30, 2024
By Laura DiAngelo, MPH The FDA’s Center for Devices and Radiological Health (CDRH) will soon convene its Patient Engagement Advisory Committee to discuss “patient-centered informed consent” policies – notably, not just for medical devices but for “FDA regulated medical products” writ large. The meeting, scheduled for October 2024, will seek input and recommendations from the committee on the process for informed consent, “new areas of focus” for informed consent, and recent policy on “key inform
Perficient: Drug Development
AUGUST 30, 2024
A major energy and utilities supplier has become the latest victim in a growing list of organizations targeted by cyberattacks. Without a quick response to an attack like this, energy companies can risk exposing customer data, cutting off energy supply, slowing or completely stopping operations, and more. According to the Department of Energy, the recent incident was responded to quickly, and had minimal lasting impact.
Agency IQ
AUGUST 30, 2024
By Sebastian Godoy, MPH , Corey Jaseph, MS, RAC , Kari Oakes In this recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations and comment periods. Fill out the form to read the full article.
Agency IQ
AUGUST 30, 2024
By Scott Stephens, MPA In the internet age, meeting regulatory obligations starts with knowing where to pinpoint the right resources in the vast ocean of information to guide you successfully through the often-labyrinthine processes of EU chemicals regulation. he good news: ECHA offers a treasure trove of online guidance on Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Classification, Labelling and Packaging (CLP), and other chemicals legislation, as well as other
Perficient: Drug Development
AUGUST 30, 2024
That is not a secret – Sitecore always used to prioritize Next.Js framework as the first-class citizen for XM Cloud. All the best and finest features tend to find their way to a given framework in the first place. However, recently, there has been much activity around the. NET Core Rendering Framework which makes a lot of sense given most of us, Sitecore tech professionals, originate from the Microsoft and.NET background.
Agency IQ
AUGUST 30, 2024
By Laura DiAngelo, MPH Seven years after its inception, the FDA has finalized its first guidance on the Voluntary Malfunction Summary Report (VMSR) program for medical devices. While industry groups had asked for some additional flexibility and clarity in response to the draft version of the document, the agency largely finalized the document in alignment with that 2022 draft.
Agency IQ
AUGUST 30, 2024
By Scott Stephens, MPA Welcome to AgencyIQ’s monthly roundup of EU chemical sector activities. This recurring feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars and meetings. Fill out the form to read the full article.
Agency IQ
AUGUST 30, 2024
FDA AdComm to discuss patient-centric informed consent The FDA’s Center for Devices and Radiological Health (CDRH) will soon convene its Patient Engagement Advisory Committee to discuss “patient-centered informed consent” policies – notably, not just for medical devices but for “FDA regulated medical products” writ large. The meeting, scheduled for October 2024, will seek input and recommendations from the committee on the process for informed consent, “new areas of focus” for informed consent,
Agency IQ
AUGUST 30, 2024
An introduction to EU chemicals guidance In the internet age, meeting regulatory obligations starts with knowing where to pinpoint the right resources in the vast ocean of information to guide you successfully through the often-labyrinthine processes of EU chemicals regulation. The good news: ECHA offers a treasure trove of online guidance on Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Classification, Labelling and Packaging (CLP), and other chemicals legislatio
Agency IQ
AUGUST 30, 2024
FDA finalizes inaugural guidance allowing certain device makers to submit quarterly malfunction reports Seven years after its inception, the FDA has finalized its first guidance on the Voluntary Malfunction Summary Report (VMSR) program for medical devices. While industry groups had asked for some additional flexibility and clarity in response to the draft version of the document, the agency largely finalized the document in alignment with that 2022 draft.
Agency IQ
AUGUST 30, 2024
What we expect EU chemical regulators to do in September 2024 Welcome to AgencyIQ’s monthly roundup of EU chemical sector activities. This recurring feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars and meetings.
Expert insights. Personalized for you.
119 
Let's personalize your content